Bill & Melinda Gates Foundation

Likarda is a biotech company focused on advancing cell therapies through innovative delivery technologies. Its proprietary Core-Shell Spherification® platform utilizes biocompatible hydrogel materials, such as Hyaluronic Acid and PEG, to create customizable microcapsules that house cell-based therapies. This platform addresses the unique requirements of various cell therapies, enabling applications in the treatment of diabetes, osteoarthritis, and joint pain. For diabetes, Likarda is developing methods to deliver islet-like cells, which have shown promising results in pre-clinical testing with animal models. In the case of osteoarthritis, encapsulated stem cells are designed for injection into the knee, providing a slow-release treatment that alleviates joint pain and promotes healing over several weeks. Likarda's versatility allows for both durable and degradable formulations, enhancing the efficacy of cell-based treatments. The company has gained recognition for its innovation, having been named one of the "50 Most Promising Start-Ups in the World" during Global Entrepreneurship Week, and has secured over $8 million in funding through various sources.

Synvect is a biotechnology company that develops innovative solutions to control mosquito populations, with a focus on eliminating disease-carrying mosquitoes. The company's core technology involves using clustered regularly interspaced short palindromic repeats (CRISPR) gene editing to sterilize mosquito eggs, thereby preventing the breeding of disease-transmitting mosquitoes. Synvect's services aim to suppress harmful mosquito populations, enabling researchers to focus on eradicating mosquito-borne illnesses through affordable and user-friendly biological methods.

Leinco Technologies is a company that specializes in the development of high-purity monoclonal antibodies, proteins, and various reagents specifically for the diagnostic and biopharmaceutical industries. They provide a range of services, including in vitro antibody and protein production, antibody conjugations, and cell banking. Leinco Technologies focuses on augmenting the early discovery process in life science research and diagnostics, as well as contributing to the innovative development of protein therapeutics. Their expertise in optimizing and adapting products enables clients to effectively meet their research and development needs.

SeamlessHR Limited is a human resource technology software company based in Lagos, Nigeria, founded in 2013. It specializes in creating enterprise-grade, cloud-based HR solutions designed to automate and optimize the entire HR process for medium to large-sized organizations. The company's comprehensive product suite includes a Recruitment Management System, HR Information System (HRIS), Performance and Competency Management, Payroll Management, Leave Management, and Learning Management System, among other modules. These tools facilitate various HR functions such as recruitment, training, payroll processing, performance evaluation, and analytics, enabling businesses to streamline their human resource operations from recruitment to retirement. Additionally, SeamlessHR provides embedded finance solutions that enhance financial security for both employers and employees.

The Independent is a global newsbrand dedicated to delivering independent news, commentary, and analysis. It operates a weekly newspaper that covers a wide range of topics, including sports, business, fashion, lifestyle, real estate, entertainment, and local news. In addition to its print publication, The Independent offers digital news articles and investigative reporting through its website and mobile applications. The company aims to keep its readers informed about current affairs and significant global incidents, positioning itself as a source for those seeking diverse perspectives and insights.

ReciBioPharm operates as a biologics company. ReciBioPharm is a division of Recipharm.

Micron Biomedical is a clinical-stage biopharmaceutical company founded in 2014 and based in Atlanta, Georgia. The company focuses on developing innovative microneedle patches designed for administering vaccines, specifically targeting influenza and polio. Its proprietary microneedle technology aims to enhance the protective and therapeutic effects of vaccines while improving patient compliance and simplifying the administration process. Through its advanced delivery methods, Micron Biomedical seeks to facilitate the development of vaccines that can address critical healthcare needs.

Aptitude Medical Systems is a biotechnology research company specializing in molecular recognition technology that utilizes aptamers to address the limitations of traditional antibodies. By developing highly stable and resistant aptamers, the company offers solutions that bind with high affinity and specificity to challenging targets, even discriminating between targets that differ by a single functional group. This innovation enables a range of applications across life sciences, diagnostics, and therapeutics, facilitating the creation of advanced products tailored to meet the stringent demands of molecular recognition. Through its partnerships, Aptitude aims to advance the capabilities of molecular diagnostics and therapeutic interventions.

Tessera Therapeutics is an early-stage life sciences company focused on pioneering Gene Writing technology, which allows for the precise insertion of therapeutic messages into the human genome. This innovative approach aims to address diseases at their source by enabling both small and large genetic alterations. By building on recent advancements in gene therapy and gene editing, Tessera Therapeutics seeks to overcome existing limitations in these fields, enhancing their efficacy and reach. Founded by Flagship Pioneering, the company aspires to establish a new category in genetic medicine that can significantly improve patient outcomes and transform healthcare.

Avanti Finance is a developer of a digital financial inclusion platform designed to enhance access to credit and affordable financial services. The company offers a flexible, open-access system that allows users and partners to create, curate, and deploy various financial products. By providing loan products and capital, Avanti Finance enables third parties to serve individuals who traditionally lack access to loans. This innovative approach facilitates microfinance loans through a cashless interface, effectively addressing the needs of underserved customer segments.

WindBorne Systems, founded in 2019 and based in Stanford, California, specializes in developing and operating a network of long-duration smart weather balloons. These high-altitude balloons are equipped with sensors to gather precise atmospheric measurements from various layers of the atmosphere. The company collects valuable data for weather forecasting, climate research, and environmental monitoring, which is then distributed to government and private weather services. By providing high-resolution atmospheric data, WindBorne Systems enhances the accuracy of weather predictions, aiding in the mitigation of severe weather events and contributing to better adaptation strategies for climate change.

VitriVax is a biotechnology startup based in Boulder, Colorado, dedicated to advancing vaccine formulation through its innovative technology platform. The company has developed proprietary atomic layering thermostable antigen and adjuvant (ALTA) technology, which aims to enhance the effectiveness, affordability, and accessibility of both human and animal vaccines worldwide. This technology allows for the creation of thermostable, single-shot vaccines that can maintain or improve immune responses, enabling the incorporation of prime and booster doses in a single administration. With significant financial backing from various organizations, including the Bill and Melinda Gates Foundation, VitriVax addresses critical barriers to global vaccination, striving to improve public health outcomes.

Magma Math is an e-learning math platform for K–12 classrooms that helps improve teaching practises and learning for students.

BioSurfaces is a developer of medical devices specializing in tissue engineering and personal care products. The company leverages advanced electrospinning technology to produce nanofibrous materials that facilitate controlled drug delivery and enhance healing at the implant site. By utilizing a room-temperature electrospinning process, BioSurfaces enables the integration of drug loading within each fiber, creating a reservoir for sustained drug release. This innovative approach allows for the creation of devices and coatings as thin as 10 micrometers, making it possible to treat diseases directly at the site of implantation. The company aims to provide next-generation solutions for the medical and personal care markets, focusing on improving patient outcomes through effective disease treatment and tissue regeneration.

INSUD PHARMA operates across the entire pharmaceutical value chain, delivering specialized expertise and experience in scientific research, development, manufacturing, sales and marketing of a wide range of value-adding active pharmaceutical ingredients (APIs), finished dosage forms (FDFs) and branded pharmaceuticals, for human and animal health.

Dyadic International is a biotechnology company based in Jupiter, Florida, with a research and development center in the Netherlands. The company focuses on the discovery, development, manufacture, and sale of enzymes and proteins for various industries, including bioenergy, bio-based chemicals, and biopharmaceuticals. Dyadic's core technology is its patented C1 fungus, which enables the efficient production of industrial enzymes and proteins at scale. This platform allows for the discovery of novel genes and proteins and has been licensed to several third parties, including Abengoa Bioenergy, BASF, and Codexis, for non-pharmaceutical applications. Dyadic seeks to maximize the value of its technologies through licensing arrangements and collaborations, providing partners with the ability to manufacture and utilize the enzymes produced through its innovative processes.

Freya Biosciences is a clinical-stage women's health company headquartered in Copenhagen and Boston, specializing in the development of microbial immunotherapies. The company focuses on addressing significant unmet medical needs across various indications by utilizing a proprietary platform to engineer and manufacture live microbes. These engineered microbes are designed to be both safe and effective for human use, facilitating the creation of innovative treatments for a range of diseases.

Based in the vibrant Phoenix Metro Area and supported by a global team, Canyon GBS® is a pioneering tech company crafting impactful solutions powered by AI. With a diverse range of offerings tailored for sectors such as higher education, public sector government agencies, non-profits, and small businesses, Canyon GBS® is dedicated to enhancing operational efficiency. Our mission is to equip organizations with powerful yet accessible AI-powered technology to better serve their constituents. Through our relentless pursuit of innovation and customer-centric approach, Canyon GBS® strives to be a trusted partner in navigating today's digital landscape.

La Ruche Health is a healthcare technology company that facilitates access to both virtual and at-home healthcare services. It offers a platform that integrates health AI with text, voice, and image capabilities, enabling patients to receive medical advice and easily book services and lab tests through applications like iOS, Android, and WhatsApp. Recognizing WhatsApp as a key distribution channel, La Ruche Health was the first to incorporate generative AI into this platform, creating an organic conversational experience that enhances accessibility for diverse user groups, including those with low literacy. Additionally, the company's medical record management system supports healthcare teams in managing and exchanging medical data, while its wellness marketplace promotes affordable access to modern health services. This comprehensive approach allows patients to connect with healthcare facilities and improves decision-making at the point of care.

PopVax is a biotechnology company that developing novel mRNA vaccines and therapeutics using computational protein design.

ApiJect Systems is a medical technology company focused on revolutionizing the delivery of injectable medications through its innovative prefilled injection devices. The ApiJect Platform allows pharmaceutical and biotech companies to efficiently produce scalable prefilled injectors for their drug products, utilizing either ApiJect's proprietary Blow-Fill-Seal packaging lines or those of its manufacturing partners. By replacing traditional materials such as glass, aluminum, rubber, and silicone with a single medical-grade plastic resin, ApiJect simplifies the supply chain and significantly reduces environmental impact. This streamlined manufacturing process dramatically accelerates production, transforming what was once a lengthy multi-step process into a rapid, efficient operation. As a result, ApiJect aims to make affordable, single-dose injectors more accessible to patients around the world.

Stellapps Technologies Private Limited is an Internet of Things (IoT) company based in Bengaluru, India, focused on enhancing the dairy supply chain. Founded in 2011, Stellapps develops a range of innovative software applications designed to optimize dairy management. Key products include SmartMoo, an automated cow-milking application aimed at reducing waste, and MooOn, a wearable device for monitoring cattle health and herd management. The company also offers smartAMCU, an automatic milk collection unit controlled via an Android IoT device, and smartCC, a cloud-based solution for managing milk chilling centers. Stellapps provides consultancy services in fodder planning, milk collection, distribution, and marketing, utilizing advanced technologies such as big data, cloud computing, and data analytics. By leveraging these technologies, Stellapps aims to improve operational efficiency and profitability for dairy farmers and cooperatives.

AN2 Therapeutics, Inc. is a clinical-stage biopharmaceutical company based in Menlo Park, California, focused on the research, development, and commercialization of innovative medicines for infectious diseases. Founded in 2017, the company aims to address significant unmet medical needs through its development of novel therapeutics. Its lead product candidate, epetraborole, is a once-daily oral treatment designed for patients suffering from chronic non-tuberculous mycobacterial lung disease. AN2 Therapeutics is committed to leveraging advanced biomedical expertise to create transformative solutions for patients dealing with serious and rare infectious diseases. The company has also established a strategic partnership with Brii Biosciences to enhance its development efforts.

CanSino Biologics focuses on the R&D, manufacturing, and commercialization of vaccine products for human use. These vaccine products include pneumococcal polysaccharide and conjugate vaccines, and a DTcP-based combo, and other items. It is also dedicated to the development of new vaccine-like recombinant adenovirus vector-based tuberculosis vaccines and a recombinant protein-based pneumococcal vaccine.

Imperial College London is a prestigious institution recognized globally for its strong focus on science, technology, engineering, medicine, and business. Situated in London with an extensive international network, it aims to leverage scientific research to address pressing global challenges. The university fosters an entrepreneurial spirit by providing resources that promote innovation and collaboration. Within this framework, the Imperial College Business School plays a crucial role by blending business acumen with cutting-edge technology. The school is dedicated to developing future business leaders through cutting-edge research that informs its postgraduate and Executive Education programs. Renowned for attracting top talent, it creates an environment that nurtures innovative thinking and encourages the development of practical solutions to real-world problems. Through its lifelong professional development services and a global alumni network, the institution supports its graduates in achieving successful careers across diverse industries worldwide.

Chemify specializes in developing a chemical digitization platform designed to facilitate drug and materials discovery as well as chemical synthesis. The company's innovative approach involves using automated synthetic hardware combined with digital XDL code to convert code into molecules on demand. This system is modular, universal, scalable, and teachable, making it highly versatile for various applications in chemical and material research. Chemify's software includes a unique chemical programming language and natural language recognition capabilities that translate synthetic procedures efficiently. Additionally, the platform features a comprehensive ontology that provides detailed insights into reaction conditions and flags potential issues, offering scientists real-time telemetry of reactions.

Radiant Biotherapeutics is an innovative biotechnology company focused on developing a modular platform for multi-valent and multi-specific therapeutics. This platform aims to advance antibody engineering by creating multi-functional biologics designed to address challenging diseases, including cancer, autoimmune disorders, and infectious diseases. By leveraging the principles of avidity and enhanced binding power, Radiant Biotherapeutics enables healthcare professionals to deliver potent therapies that have the potential to transform treatment outcomes for patients. The company's commitment to pioneering these advanced therapeutics positions it at the forefront of the biotherapeutics field, striving to unlock new avenues for patient care.

Eyam Vaccines and Immunotherapeutics is a life science and medical research company focused on the development of vaccines to combat infectious diseases. The company specializes in researching vaccines that target the spike glycoprotein, which is crucial for generating neutralizing antibodies against pathogens such as the novel coronavirus. Eyam employs a self-amplifying vaccine platform that enables the design of low-dose vaccines with advanced targeting capabilities, ensuring comprehensive protection, including against emerging variants. Through its innovative approach, the company aims to address pressing healthcare challenges and enhance public health outcomes.

Field develops innovative pharmaceutical supply-chain technology aimed at enhancing healthcare delivery in rapidly growing regions. The company focuses on digitizing and modernizing supply chains, making them more effective and scalable. By providing accessible and efficient solutions, Field strengthens partnerships with communities and supports the promise of healthcare for millions. Its platform is designed to empower governments and businesses, transforming the way healthcare services are provided globally.

Upsolve is a nonprofit organization based in New York City that assists low-income Americans in navigating the bankruptcy process. Founded in June 2016 by Jonathan Petts and Rohan Pavuluri, Upsolve offers a free online tool that guides users through a series of questions to generate the necessary Chapter 7 bankruptcy forms. Following this, the organization's lawyers review the completed forms to ensure accuracy and compliance. By automating the bankruptcy filing process, Upsolve aims to provide essential financial guidance and support to those facing sudden financial hardships, helping them achieve a fresh start.

Propel, Inc. is a software development company based in Brooklyn, New York, established in 2014. The company focuses on creating mobile applications aimed at improving the financial health of low-income Americans. Its primary product, Providers, is a free app designed for EBT cardholders, enabling them to manage their government benefits, such as SNAP and rental assistance. The app also helps users track their finances, save on essential purchases, and earn cash through various incentives. Propel's mission is to empower individuals by providing tools that facilitate better budgeting and financial management.

Legume Technology is a producer of organic, contaminant-free, biostimulant products that are proven to increase yield. They provide services such as physicochemical improvement of pellets, compatibility testing, coating machinery, private labelling, marketing support, registration support from legume technology, pre-treatment inoculant training, application strategy and techniques. Their products like liquifix, liquifix 120, legumefix, molyfix, rootfix, extensive,and mycofix. They provide support for crops such as soya, peas, lupin, lucerne, wheat, chickpeas, clover, corn, and sunflower.

Immorna is a biotechnology company focused on the development of RNA-based therapeutics and vaccines. The company employs various RNA platforms, including conventional, self-replicating, and circular RNA, to create innovative treatment solutions. Immorna has established a comprehensive management console that supports RNA synthesis, purification, and analytical testing, which is designed for both clinical and commercial applications. With advanced screening tools, the company has developed a range of RNA delivery vehicles, including polymers and lipid nanoparticles that utilize proprietary ionizable cationic lipids. This portfolio positions Immorna to effectively address a variety of medical needs through its cutting-edge RNA technology.

Noze is a pioneering company in digital odor perception, recognized for creating an advanced digital nose that accurately detects and identifies odors in various real-world contexts. Leveraging cutting-edge machine perception technology and a specialized sensor developed from NASA innovations, Noze aims to enhance human health and wellbeing. The company's technology mimics the human olfactory system, allowing it to gather data on air quality and chemical footprints based on scent. This enables healthcare providers to monitor and predict health changes, diagnose diseases, and perform routine screenings through breath-based odor biomarkers. Ultimately, Noze is dedicated to facilitating real-time disease detection at any point-of-care, thereby significantly improving patient outcomes.

Schrödinger is a healthcare-focused software company that specializes in computational drug design, serving pharmaceutical and biotechnology research sectors. Established in 1990, it offers a powerful computational platform that aids biopharmaceutical and industrial companies, as well as academic and government institutions, in their research efforts globally. Schrödinger operates through two main segments: Software and Drug Discovery. The Software segment supplies solutions aimed at enhancing the drug discovery process across the life sciences and materials science industries. Meanwhile, the Drug Discovery segment generates revenue through a portfolio of preclinical and clinical programs, both independently and through collaborative efforts. The company is committed to advancing science and talent to support its platform and has over 400 employees, engaging with customers and collaborators in more than 70 countries.

RiseKit, Inc. is a software company based in Chicago, Illinois, founded in 2016. It focuses on connecting entry to mid-level job seekers, particularly from underserved communities, with employment opportunities, training programs, and supportive services. By leveraging its platform, RiseKit aims to eliminate barriers to employment based on geographic and socioeconomic factors. The company's solutions serve nonprofits, employers, government entities, and community organizations, facilitating efficient connections between job candidates and available resources. RiseKit's mission is to ensure that all individuals, regardless of their background, have access to meaningful career pathways and that organizations can effectively measure their impact on the communities they serve.

Snipr Biome ApS is a biotechnology company based in Copenhagen, Denmark, that focuses on developing innovative CRISPR technology for the treatment of microbial diseases. Incorporated in 2017, the company aims to revolutionize healthcare by utilizing a programmable approach to the adaptive immune system, enabling the targeted elimination of hazardous bacteria based on their specific DNA sequences. Snipr Biome's novel medicines are designed to provide health professionals with effective tools for microbiome engineering, allowing for selective targeting and destruction of harmful bacteria in vivo.

Ethris GmbH is a biotechnology company based in Planegg, Germany, specializing in the development of innovative therapeutic solutions for diseases with unmet medical needs. The company has a focus on transcript therapeutics, particularly through its SNIM RNA platform, which offers a novel approach to treating various conditions by enabling the production of therapeutic proteins within the patient’s body. This platform presents an alternative to traditional recombinant protein and gene therapies, addressing a range of diseases, including rare and genetically predetermined conditions. Ethris also develops Magnetovax, a personalized tumor vaccine platform that utilizes magnetic fields for localized activation in tumors. The company has established strategic research collaborations with major pharmaceutical firms, enhancing its capabilities in regenerative medicine and therapeutic development. Founded in 2009, Ethris continues to advance its technologies to meet diverse medical needs.

The Alan Turing Institute is the national institute for data science. The Institute is named in honour of Alan Turing (23 June 1912 – 7 June 1954), whose pioneering work in theoretical and applied mathematics, engineering and computing are considered to be the key disciplines comprising the emerging field of data science.

Ben-Gurion University of the Negev is one of Israel’s leading research universities and among the world leaders in many fields. It has around 20,000 students and 4,000 faculty members in the Faculties of Engineering Sciences; Health Sciences; Natural Sciences; the Pinchas Sapir Faculty of Humanities and Social Sciences; the Guilford Glazer Faculty of Business and Management; the Joyce and Irving Goldman School of Medicine; the Kreitman School of Advanced Graduate Studies; and the Albert Katz International School for Desert Studies. More than 100,000 alumni play important roles in all areas of research and development, industry, health care, the economy, society, culture and education in Israel. The University has three main campuses: The Marcus Family Campus in Beer-Sheva; the research campus at Sede Boqer and the Eilat Campus, and is home to national and multi-disciplinary research institutes: the National Institute for Biotechnology in the Negev; the National Institute of Solar Energy; the Ilse Katz Institute for Nanoscale Science and Technology; the Jacob Blaustein Institutes for Desert Research; the Ben-Gurion Research Institute for the Study of Israel & Zionism, and Heksherim - The Research Institute for Jewish and Israeli Literature and Culture.

Shomvob Technologies is an integrated fintech and HR-tech platform operating in Bangladesh, focused on empowering the frontline workforce. The company aims to enhance job opportunities by assisting individuals in creating a digital professional identity and fostering a wide network. This enables users to access employment that aligns with their skills, qualifications, and expectations. In addition to its employment services, Shomvob offers a comprehensive payroll financing product as part of its commitment to financial inclusion, further supporting the workforce in achieving stability and growth.

Nanite is a biotechnology company focused on non-viral gene delivery through the development of programmable polymer nanoparticles. Utilizing an artificial intelligence-driven platform, Nanite integrates advanced high-throughput experimental and computational techniques to create tailored delivery vehicles capable of transporting a diverse array of genetic materials with specific targeting capabilities. This innovative approach aims to assist scientists in functional chemistry by providing therapeutically relevant solutions for gene delivery, enhancing the potential for various medical applications and indications.

Surf Bio is a preclinical biopharmaceutical company focused on developing innovative therapeutic solutions through its next-generation surfactant technology. This novel biotechnology platform aims to enhance drug effectiveness across various therapeutic areas, including diabetes, oncology, infectious diseases, and gene therapy. By utilizing this advanced technology, Surf Bio seeks to provide healthcare organizations worldwide with access to improved drugs that can better address the needs of patients suffering from critical diseases.

Owlstone Medical, established in 2003 and headquartered in Cambridge, UK, specializes in developing and commercializing breathalyzers for clinical diagnostics and precision medicine. The company's core technology, FAIMS, enables the detection of volatile organic compounds in breath, facilitating the discovery of non-invasive biomarkers for various diseases. Owlstone Medical's product portfolio includes breath samplers like ReCIVA and CASPER, as well as analytical tools such as Lonestar and ATLAS, catering to applications like lung cancer, asthma, and gastrointestinal disorders. The company collaborates with market leaders to integrate its technology into next-generation chemical sensing products and has received funding from the UK's Department of Defense to develop a handheld device for enhanced sensitivity and selectivity. Owlstone Medical aims to become a global leader in non-invasive diagnostics, with a focus on early disease detection and a pipeline of medical applications, including colon and lung cancer screening.

Owlstone Medical, established in 2003 and headquartered in Cambridge, UK, specializes in developing and commercializing breathalyzers for clinical diagnostics and precision medicine. The company's core technology, FAIMS, enables the detection of volatile organic compounds in breath, facilitating the discovery of non-invasive biomarkers for various diseases. Owlstone Medical's product portfolio includes breath samplers like ReCIVA and CASPER, as well as analytical tools such as Lonestar and ATLAS, catering to applications like lung cancer, asthma, and gastrointestinal disorders. The company collaborates with market leaders to integrate its technology into next-generation chemical sensing products and has received funding from the UK's Department of Defense to develop a handheld device for enhanced sensitivity and selectivity. Owlstone Medical aims to become a global leader in non-invasive diagnostics, with a focus on early disease detection and a pipeline of medical applications, including colon and lung cancer screening.

Sibel Health, established in 2018 and headquartered in Evanston, Illinois, specializes in advanced monitoring solutions for healthcare. The company develops soft, flexible sensors that provide clinical-grade, wireless vital signs monitoring, including heart rate, respiratory rate, skin temperature, body position, and activities. These sensors are designed for use on patients and pregnant mothers, offering a comprehensive physiological monitoring platform with advanced analytics for both clinical care and research applications. Sibel Health's innovative digital health solutions are tailored for the pharmaceutical and clinical research sectors, enhancing healthcare delivery and patient outcomes.

Corner Therapeutics is a biotechnology research company focused on advancing immunotherapy solutions. The company specializes in stimulating exceptional memory T cells to achieve lifelong immunity. It has developed a versatile dendritic cell hyperactivation (hDC) platform that induces strong T-cell responses, aiming to deliver robust and durable immunity against a wide array of cancers and infectious diseases. By providing these innovative technologies, Corner Therapeutics enables healthcare providers to enhance immune responses and promote long-lasting immunity, positioning itself at the forefront of immunotherapy research.

Pula GmbH is an insurance intermediary based in Mollis, Switzerland, specializing in agricultural insurance broking services. The company focuses on providing data-driven insurance solutions for small-scale farmers across six countries in Africa. By leveraging machine learning and analyzing weather patterns and farm losses, Pula helps farmers navigate climate risks and enhance their agricultural practices. Through the use of mobile technology, Pula empowers hundreds of thousands of smallholders to protect their crops and make informed financial decisions, ultimately enabling them to invest in their farms and improve their overall income.

Ginkgo Bioworks is a biotechnology firm based in Boston, Massachusetts, that specializes in designing, engineering, and developing custom microbes and organisms for various applications. Founded in 2008, the company focuses on discovering and licensing molecules used in flavors, sweeteners, cosmetic ingredients, crop treatments, and pharmaceuticals. In addition to these capabilities, Ginkgo Bioworks provides probiotic bacteria that help protect against infections and creates extensive libraries of molecules. The firm operates across multiple markets, including cultured ingredients, carbon mitigation, probiotics, and natural product discovery. It has reorganized its operations into two primary segments: Cell Engineering and Biosecurity, with a significant portion of its revenue generated from biosecurity-related data analytics and services.

Antibody Solutions provides antigen design, polyclonal antibody generation, research and drug development for biopharmaceutical companies.

Detect-ION is a cutting-edge deep-tech startup that specializes in the development of sensors and systems for a variety of applications, with a focus on innovation and technological excellence.

Noze is a pioneering company in digital odor perception, recognized for creating an advanced digital nose that accurately detects and identifies odors in various real-world contexts. Leveraging cutting-edge machine perception technology and a specialized sensor developed from NASA innovations, Noze aims to enhance human health and wellbeing. The company's technology mimics the human olfactory system, allowing it to gather data on air quality and chemical footprints based on scent. This enables healthcare providers to monitor and predict health changes, diagnose diseases, and perform routine screenings through breath-based odor biomarkers. Ultimately, Noze is dedicated to facilitating real-time disease detection at any point-of-care, thereby significantly improving patient outcomes.

Phase Genomics is a biotechnology company based in Seattle, Washington, founded in 2015. The company specializes in developing technology for ProxiMeta Hi-C genome assembly and metagenome deconvolution. Phase Genomics' platform aims to facilitate transformative discoveries in agriculture, human health, and industrial biology by providing scientists with highly accurate and detailed genomes and metagenomes. This enables researchers to make significant breakthroughs across various fields.

Food Fortification Initiative is a non-profit organization that provides the fortification of industrially milled flour and rice globally.

PhaSER Biomedical is Exploiting the 8HUM mouse, a unique mouse model with multiple utilities in drug discovery, and development.

C16 Biosciences, Inc. is a biotechnology company based in New York that specializes in producing sustainable alternatives to palm oil through microbial fermentation. Founded in 2017, the company employs its innovative biomanufacturing platform to create scalable and environmentally friendly ingredients for food manufacturers, refiners, and consumers. C16 Biosciences has developed the Palmless™ platform, which features its first biodesigned ingredient, Torula oil, known for its premium bioactive properties that support skin and hair health. By focusing on sustainable solutions, C16 Biosciences aims to help solidify supply chains for consumer product manufacturers while addressing the environmental challenges associated with traditional palm oil production.

ProteinLogic’s ImmiPrint® technology impacts the emerging market for diagnostic, predictive, prognostic and other biomarker applications.

Picnic is a rapidly expanding technology company that operates as an online supermarket, offering a modern home delivery system for fast-moving consumer goods. The company focuses on providing grocery shopping services at competitive prices without delivery costs. Through its platform, users can place orders for a wide range of products sourced from local bakers, greengrocers, and other suppliers. Picnic utilizes electric vehicles for deliveries, ensuring that customers receive their groceries conveniently at their doorsteps while promoting environmentally friendly practices.

Sail Biomedicines is a biotechnology company developing innovative medicines using circular RNA technology and programmable nanoparticles. Its platform, Endless RNA (eRNA), combined with unique, naturally-derived nanoparticles, enables the comprehensive programming of drugs, enhancing their potency and targeting capabilities. The company aims to transform patient care by leveraging artificial intelligence and advanced delivery systems to create first-in-class therapeutics.

Radiant Biotherapeutics is an innovative biotechnology company focused on developing a modular platform for multi-valent and multi-specific therapeutics. This platform aims to advance antibody engineering by creating multi-functional biologics designed to address challenging diseases, including cancer, autoimmune disorders, and infectious diseases. By leveraging the principles of avidity and enhanced binding power, Radiant Biotherapeutics enables healthcare professionals to deliver potent therapies that have the potential to transform treatment outcomes for patients. The company's commitment to pioneering these advanced therapeutics positions it at the forefront of the biotherapeutics field, striving to unlock new avenues for patient care.

Brightseed, Inc. is a pioneering biosciences company based in San Francisco, California, founded in 2017. It specializes in the discovery of bioactive compounds in plants that have beneficial effects on human health, particularly for chronic disease management. Utilizing its proprietary Forager platform, which incorporates artificial intelligence and machine learning, Brightseed accelerates the identification and validation of these naturally occurring compounds, transforming what was once a lengthy process into a matter of months. By mapping bioactives to specific health outcomes, Brightseed provides valuable insights and science-backed solutions to partners across the consumer health continuum. The company's innovative approach aims to illuminate the connections between nature and human health, ultimately improving quality of life and addressing health challenges through the exploration of previously uncharted plant compounds.

LTS is a leading pharmaceutical technology company that develops and manufactures innovative drug delivery systems such as Transdermal Patches ("TTS"​) and Oral Thin Films ("OTF"​) for the pharmaceutical industry. While we continuously refine our TTS and OTF technologies further, we also research complementary Micro Array Patches for the transdermal delivery of large molecule, biological actives. Incorporated in 1984, we operate today from two sites in Andernach, Germany and West Caldwell/NJ, USA, plus representative office in Shanghai/China.

Evotec is a drug discovery partnership firm that collaborates with pharmaceutical and biotechnology companies, academic institutions, and nonprofit organizations to advance innovative therapeutic solutions. The company specializes in a range of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. Approximately 80% of its revenue comes from shared research and development services, which involve fee-for-service work and integrated drug discovery collaborations utilizing proprietary assets. The remaining 20% of sales derive from its Just-Evotec Biologics segment, which provides contract development and manufacturing organization services for biologics. Evotec's approach emphasizes collaboration with various stakeholders, including patient advocacy groups and venture capitalists, to enhance drug discovery and development processes.

Molecular Loop is a biotechnology company focused on DNA sequencing. The company offers a unique approach to sequencing through its Molecular Loop targeting technology, which eliminates the need for a separate library preparation process. This innovation allows for amplicons designed to overlap extensively across target strands, providing sequence data without the added complexity and costs associated with traditional shotgun library methods. Additionally, Molecular Loop provides custom assays based on user-provided content, along with expanded and customizable carrier screening panels and research panels for SARS-CoV-2. These offerings enable healthcare professionals and researchers to access efficient systems for production-scale targeted sequencing applications.

Ginkgo Bioworks is a biotechnology firm based in Boston, Massachusetts, that specializes in designing, engineering, and developing custom microbes and organisms for various applications. Founded in 2008, the company focuses on discovering and licensing molecules used in flavors, sweeteners, cosmetic ingredients, crop treatments, and pharmaceuticals. In addition to these capabilities, Ginkgo Bioworks provides probiotic bacteria that help protect against infections and creates extensive libraries of molecules. The firm operates across multiple markets, including cultured ingredients, carbon mitigation, probiotics, and natural product discovery. It has reorganized its operations into two primary segments: Cell Engineering and Biosecurity, with a significant portion of its revenue generated from biosecurity-related data analytics and services.

Naobios is a contract development and manufacturing organization (CDMO) located in Saint Herblain, France. The company specializes in bioprocess development and offers good manufacturing practice (GMP) production services for clinical batches of various biological products, including viral vaccines, oncolytic viruses, viral vectors, and challenge agents. With expertise in optimizing production processes, Naobios supports the development of live vaccine products, contributing to advancements in biopharmaceutical manufacturing.

VitriVax is a biotechnology startup based in Boulder, Colorado, dedicated to advancing vaccine formulation through its innovative technology platform. The company has developed proprietary atomic layering thermostable antigen and adjuvant (ALTA) technology, which aims to enhance the effectiveness, affordability, and accessibility of both human and animal vaccines worldwide. This technology allows for the creation of thermostable, single-shot vaccines that can maintain or improve immune responses, enabling the incorporation of prime and booster doses in a single administration. With significant financial backing from various organizations, including the Bill and Melinda Gates Foundation, VitriVax addresses critical barriers to global vaccination, striving to improve public health outcomes.

LTS is a leading pharmaceutical technology company that develops and manufactures innovative drug delivery systems such as Transdermal Patches ("TTS"​) and Oral Thin Films ("OTF"​) for the pharmaceutical industry. While we continuously refine our TTS and OTF technologies further, we also research complementary Micro Array Patches for the transdermal delivery of large molecule, biological actives. Incorporated in 1984, we operate today from two sites in Andernach, Germany and West Caldwell/NJ, USA, plus representative office in Shanghai/China.

Kyron Learning is an EdTech company focused on providing equitable access to personalized education through its online platform. The platform utilizes conversational artificial intelligence technology to monitor and assess student performance, identifying areas of difficulty that require attention from educators. By facilitating one-on-one educational tutorials, Kyron Learning enables tutors and educational institutions to deliver interactive and high-quality instruction tailored to individual student needs.

Micron Biomedical is a clinical-stage biopharmaceutical company founded in 2014 and based in Atlanta, Georgia. The company focuses on developing innovative microneedle patches designed for administering vaccines, specifically targeting influenza and polio. Its proprietary microneedle technology aims to enhance the protective and therapeutic effects of vaccines while improving patient compliance and simplifying the administration process. Through its advanced delivery methods, Micron Biomedical seeks to facilitate the development of vaccines that can address critical healthcare needs.

Osmo is a company that develops an artificial intelligence platform designed to give computers a sense of smell. By combining advanced AI with olfactory science, Osmo addresses significant challenges in the fragrance industry while also aiming to enhance human health and well-being. The company creates aroma molecules for a variety of products, including perfumes, shampoos, lotions, and candles. Additionally, Osmo's technology has the potential to detect diseases earlier and track pandemics, thereby improving consumer experience and overall wellness. Through its innovative approach, Osmo seeks to transform the way scent is integrated into everyday life and contribute positively to public health.

Philips, established in 1891, is a Dutch diversified technology company that focuses on improving people's health and well-being through meaningful innovation. The company operates in three segments: Diagnosis & Treatment, Connected Care, and Personal Health. Philips Healthcare, a division of Philips, is a leader in diagnostic imaging, image-guided therapy, patient monitoring, health informatics, consumer health, and home care. It offers a wide range of products such as CT scanners, MRI machines, ultrasound equipment, and more, aiming to enhance preventive care, diagnosis, and treatment. Additionally, Philips Research drives innovation across these segments, while the Philips Foundation focuses on reducing healthcare inequality through access to quality care for disadvantaged communities. The company also provides lighting solutions and consumer lifestyle products, including personal care and oral healthcare items.

BiomEdit is an innovation company focused on developing novel probiotics, microbiome-derived bioactives, and engineered microbial medicines to meet unmet needs in animal health. The company aims to address significant challenges in animal agriculture and food security by harnessing the potential of the microbiome. BiomEdit employs a unique platform that combines high-throughput sequencing and data analytics to efficiently discover and screen new probiotic species and bioactive molecules. These innovations can be engineered for enhanced stability and improved production of beneficial metabolites or immune-modulating proteins. The resulting probiotics and microbially-derived compounds represent advanced solutions designed to promote animal health while minimizing reliance on antibiotics.

Axmed is a business focuses on LMICs and strengthens the purchasing power of these markets to ensure the supply of cost-effective, high-quality medicines. We partner exclusively with authorized, high-quality pharmaceutical companies and certified caregivers to accelerate access to medicines.

CanSino Biologics Inc. is a biotechnology company based in Tianjin, China, focused on the research, development, manufacturing, and commercialization of vaccines. The company is actively developing a range of vaccines, including those for Ebola, meningitis, pertussis, and pneumococcal diseases, with multiple candidates currently in various phases of clinical trials. Notable products under development include the recombinant coronavirus vaccine Ad5-nCov, as well as several preclinical stage vaccines targeting adenovirus, Zika virus, meningitis, shingles, and polio. CanSino collaborates with the National Research Council of Canada to advance COVID-19 vaccine initiatives and has a co-development agreement with Precision NanoSystems to create an mRNA lipid nanoparticle vaccine against COVID-19. Founded in 2009, CanSino aims to meet the unmet medical needs in China and other emerging markets by providing high-quality vaccines at affordable prices.

Salient creates a weather intelligence platform that combines novel ocean and land-surface data with machine learning and climate expertise to provide accurate subseasonal-to-seasonal (S2S) weather forecasts 2 to 52 weeks ahead. Salient's tools sift through large datasets to identify complex climate system relationships in order to provide accurate forecasts used in agriculture, energy, finance, supply chain, and other industries. Salient utilizes scientific knowledge to assist individuals and organizations in better understanding and preparing for the increasing volatility of climate change.

STRM.BIO is a biotechnology company focused on advancing gene therapy through the innovative use of extracellular vesicles (EVs). By leveraging the natural properties of EVs, which can efficiently deliver nucleic acids and proteins, the company aims to establish a new class of therapeutics that enhance the effectiveness of existing treatments while simplifying the delivery process. STRM.BIO emphasizes safety and practicality in its approach, utilizing EVs as low-immunogenic carriers that can be mass-produced for commercial use. The company's mission is to fulfill the potential of gene therapy by providing patients with more effective and accessible treatment options.

Scentian Bio is a biotechnology company that develops innovative biosensor devices by integrating insect biology with nanotechnology. These devices leverage insect odorant receptors to create advanced sensing solutions tailored for applications in the medical and food industries. Scentian Bio's technology employs machine learning to detect volatile organic compounds, enabling the identification of off-notes in food and beverages, as well as the detection of fraud and adulteration in raw materials. By providing access to this sophisticated sensor technology, Scentian Bio aims to translate nature's sensory capabilities into practical applications for various commercial uses.

AN2 Therapeutics, Inc. is a clinical-stage biopharmaceutical company based in Menlo Park, California, focused on the research, development, and commercialization of innovative medicines for infectious diseases. Founded in 2017, the company aims to address significant unmet medical needs through its development of novel therapeutics. Its lead product candidate, epetraborole, is a once-daily oral treatment designed for patients suffering from chronic non-tuberculous mycobacterial lung disease. AN2 Therapeutics is committed to leveraging advanced biomedical expertise to create transformative solutions for patients dealing with serious and rare infectious diseases. The company has also established a strategic partnership with Brii Biosciences to enhance its development efforts.

GE Healthcare is a multinational healthcare company based in Chicago, Illinois, that specializes in manufacturing a diverse range of medical equipment and technologies. Founded in 1892, the company offers products and services including medical imaging, information technologies, medical diagnostics, and patient monitoring systems. GE Healthcare also supports drug discovery and biopharmaceutical manufacturing through intelligent devices and data analytics. The company aims to enhance patient care and outcomes by providing innovative healthcare solutions utilized in hospitals, clinics, research institutions, and pharmaceutical companies globally. By focusing on precision health and digitizing healthcare, GE Healthcare seeks to improve productivity and health outcomes for patients and healthcare providers alike. Additionally, the company pursues an aggressive acquisition strategy to strengthen its presence in emerging markets and expand its life sciences portfolio.

Anheuser-Busch InBev is the world's largest brewer and a leading player in the consumer goods sector. Established through the 2008 merger of Belgium-based InBev and US-based Anheuser-Busch, the company boasts a diverse portfolio that includes six of the top ten beer brands by volume. It distributes a total of 23 brands that generate over $1 billion in retail sales. In addition to its brewing operations, Anheuser-Busch InBev manufactures and distributes both alcoholic and non-alcoholic beverages. The company has also developed a proprietary business-to-business platform, BEES, which digitizes the retail experience by connecting various steps in the distribution process to enhance consumer access. Anheuser-Busch InBev's strategic acquisitions, including the purchase of SABMiller in 2016, have further solidified its position in the global market.

Fulbright University Vietnam, based in Ho Chi Minh City, is a higher education institution that aims to bridge the gap between Vietnam's educational priorities and the demands of its job market. It offers interdisciplinary undergraduate and graduate programs in liberal arts, sciences, and engineering, focusing on developing students' practical skills and critical thinking. The university is committed to fostering diversity and accessibility through financial aid and scholarship opportunities. Its assets are managed by an executive management team.

Nuoc.Solutions aims to create and foster innovative, sustainable, and efficient solutions to pressing water problems in Vietnam.

The American University of Beirut (AUB) is a prominent educational institution established in 1866, originally known as Syrian Protestant College until its name change in 1920. Located in Beirut, Lebanon, AUB follows the American liberal arts model and offers a comprehensive range of programs, including bachelor's, master's, M.D., and Ph.D. degrees across six faculties: Agricultural and Food Sciences, Arts and Sciences, Engineering and Architecture, Health Sciences, Medicine, and Business. The university promotes a teaching-centered research environment and emphasizes critical thinking, personal integrity, and civic responsibility among its approximately 8,000 students. With a faculty of around 800, AUB maintains a student-faculty ratio of 11.2 to 1. The institution is accredited by the Commission on Higher Education of the Middle States Association of Colleges and Schools in the United States and has been coeducational since 1922, with a balanced student demographic of 50 percent male and 50 percent female. The primary language of instruction is English, except for courses offered in the Arabic Department and other language programs.

The Lahore University of Management Sciences (LUMS) is a national university, established by sponsors belonging to the country’s leading private and public sector corporations. The goal of the sponsors is to develop an institution, which would provide rigorous academic and intellectual training and a viable alternative to education comparable to leading universities across the world.

EHA Clinics is a healthcare service provider focused on delivering accessible, effective, and affordable quality healthcare. The company offers a comprehensive network that includes integrated services such as routine medical care, laboratory services, pharmacy, optometry, dental care, urgent care, and specialist consultations. EHA Clinics aims to enhance the healthcare experience for its members by utilizing technology and a skilled team, ensuring improved health outcomes and cost efficiency. Their services are available 24/7 through a variety of platforms, including physical locations, telehealth virtual visits, and home care, allowing members to receive timely and convenient medical attention.

Bactolife is a company focused on addressing the global challenge of antimicrobial resistance through innovative solutions. It develops proprietary Binding Protein ingredients aimed at fortifying the gut microbiome, thereby reducing the risk of gastrointestinal infections in both humans and animals. Bactolife's platform is designed to neutralize harmful pathogens and their toxins while preserving beneficial microbes, thus promoting overall gut health. By enhancing gut microbiome modulation technologies, the company seeks to diminish reliance on traditional antimicrobials, ultimately improving health outcomes and contributing to the fight against antimicrobial resistance.

A-Alpha Bio, Inc. is a biotechnology company specializing in synthetic biology and advanced quantitative measurement of protein interactions to facilitate drug development. Founded in 2017 and headquartered in Seattle, Washington, the company offers its proprietary AlphaSeq platform, which enables high-throughput mapping of protein-protein interactions. This technology allows for the simultaneous identification and quantification of interactions among thousands of protein pairs, streamlining the drug discovery process by aiding in the identification of potential drug targets and enhancing the understanding of disease mechanisms. By providing biologics and molecular glue discovery and optimization services, A-Alpha Bio supports pharmaceutical companies in optimizing binding and specificity to multiple target proteins. The team comprises synthetic biologists, structural biologists, and next-generation sequencing experts dedicated to overcoming challenges in the drug development process.

Aptitude Medical Systems is a biotechnology research company specializing in molecular recognition technology that utilizes aptamers to address the limitations of traditional antibodies. By developing highly stable and resistant aptamers, the company offers solutions that bind with high affinity and specificity to challenging targets, even discriminating between targets that differ by a single functional group. This innovation enables a range of applications across life sciences, diagnostics, and therapeutics, facilitating the creation of advanced products tailored to meet the stringent demands of molecular recognition. Through its partnerships, Aptitude aims to advance the capabilities of molecular diagnostics and therapeutic interventions.

Co-Diagnostics, Inc. is a molecular diagnostics company based in Salt Lake City, Utah, founded in 2013. The company specializes in the development, manufacture, and marketing of advanced diagnostic technologies that focus on the detection and analysis of nucleic acid molecules, such as DNA and RNA. In addition to creating reagents for diagnostic tests, Co-Diagnostics offers self-contained lab systems that incorporate diagnostic equipment from other manufacturers. The company also leverages its proprietary technology to design targeted tests for identifying genetic markers, which can be utilized in various industries beyond infectious diseases, while licensing these tests to specific customers.

SoapBox Labs Ltd., established in 2013 and based in Dublin, Ireland, specializes in developing automated speech recognition solutions tailored to children's voices. The company offers a range of products, including reading and language learning tools, as well as gaming solutions that incorporate voice control, AR, VR, and IoT. Their technology, which is COPPA and GDPR compliant, is integrated into various applications such as toys, robotics, and educational platforms, catering to multiple languages and providing accurate, age-appropriate, and safe voice-enabled experiences for children.

Aphea.Bio is a company focused on developing next-generation biopesticides and biostimulants derived from natural microorganisms. Its biopesticides serve as an alternative to conventional chemical pesticides, addressing the increasing pressure on synthetic chemical use in agriculture. Additionally, the company creates biostimulants that enhance crop growth by improving the uptake of nutrients from the soil. Aphea.Bio's products aim to sustainably increase crop yields and health, specifically targeting crops such as maize and wheat. By utilizing proprietary technologies, the company accelerates the discovery of innovative biocontrol and biostimulant solutions, enabling farmers to manage pests, diseases, and fertilizer application more effectively.

Myna Mahila Foundation is a non-governmental organization that provides employment and skills to women in slum neighborhoods.

Latham BioPharm Group is a firm specializing in life sciences, offering comprehensive expertise in business development, program management, quality assurance, regulatory affairs, and strategic consulting. With a team that boasts an average of over 20 years of experience, including roles as senior executives in both startups and Fortune 200 companies, Latham BioPharm has a strong foundation in guiding clients through the complexities of product development. The company has a proven track record in biodefense and pandemic response, having successfully assisted clients in identifying and securing funding, managing programs, and monetizing opportunities across various sectors. Their services include strategy and portfolio analysis, market research, and connecting clients with target markets to enhance decision-making. Latham BioPharm's expertise has contributed to generating substantial government funding and licensing fees, positioning them as a key partner in advancing innovations in vaccines, therapeutics, medical devices, and diagnostics.

Lectrolyst is a technology company that specializes in developing electrochemical solutions for chemical production. They use electricity to convert waste CO2 and renewable feedstocks into fine chemical components, offering scalable, on-site solutions tailored to industrial clients' needs. This process aims to reduce carbon emissions and promote more sustainable chemical production, helping clients minimize their environmental impact and reliance on fossil fuels.

Aegis Life is a biotechnology company focused on advancing nucleic acid delivery technology, specifically through its proprietary platform known as fusogenix PLV. With over two decades of dedicated research and development, the company aims to facilitate the discovery, clinical development, and manufacturing of vaccines and therapeutics targeting infectious diseases. Aegis Life's innovative technology enables the rapid development of solutions to combat a range of health threats, including COVID-19 and other emerging contagions. Through its efforts, the company supports the pharmaceutical industry in addressing urgent public health challenges effectively.

The Council for Scientific and Industrial Research, commonly known as the CSIR, is a world-class African research and development organisation established through an Act of Parliament in 1945. The CSIR undertakes directed, multidisciplinary research and technological innovation that contributes to the improved quality of life of South Africans. The organisation plays a key role in supporting government’s programmes through directed research that is aligned with the country’s priorities, the organisation’s mandate and its science, engineering and technology competences. Key issues that the CSIR seeks to address through various interventions include: creating a vibrant economy and employment opportunities; building a capable state that is able to consistently deliver high-quality services for all South Africans; contributing to the development of economic and social infrastructure like transport, energy, water resources and ICT networks. The CSIR’s shareholder is the South African Parliament, held in proxy by the Minister of Science and Technology.

Hyperfine is a pioneering medical device company known for developing Swoop, the first FDA-cleared point-of-care MRI system. Swoop is designed to enhance patient access to rapid diagnosis and treatment, regardless of socioeconomic factors or geographic location. This innovative portable MRI system operates at a lower magnetic field strength than traditional MRI machines, allowing for high-quality imaging in a variety of clinical environments. Swoop can be easily transported to a patient's bedside, requires only a standard electrical outlet, and is controlled via an iPad, facilitating quick scans that support critical decision-making in settings such as emergency departments and intensive care units. Hyperfine generates revenue through the sale of its MRI devices as well as service sales, which include subscriptions for bundled devices, maintenance, and software.

The Medicines for All Institute, operating under the auspices of the Virginia Commonwealth University School of Engineering.